Video-Based Intervention for BRCA Gene Mutations
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a video sent by text can help individuals with BRCA gene mutations encourage their families to undergo testing. The goal is to simplify understanding of the risks and facilitate discussions about testing, which can aid in managing and reducing cancer risk. Participants will receive either a short video (video-based intervention) or a letter containing important information to share with their relatives. This trial suits individuals who have tested positive for the BRCA1 or BRCA2 gene mutations and wish to inform their family. As an unphased study, this trial offers a unique opportunity to contribute to research that could simplify family communication about genetic risks.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this video-based intervention is safe?
Research shows that video-based programs are generally well-received and have been used safely in many situations. Although specific safety details for the video program in this BRCA gene mutation study are unavailable, similar programs have proven successful and satisfying in other areas. These programs typically share information through videos, which is non-invasive and poses no physical risks to participants. Therefore, participating in this trial and receiving information through video messages is likely safe and comfortable.12345
Why are researchers excited about this trial?
Researchers are excited about the video-based intervention for BRCA gene mutations because it uses modern communication methods to facilitate family discussions about genetic risks. Unlike traditional approaches that often involve genetic counseling sessions or mailed letters, this intervention delivers a concise, 2-minute video via text message. This allows participants to easily share crucial information with relatives through text, email, or social media, making it more accessible and engaging. By using familiar digital platforms, the intervention could improve the dissemination of important health information and potentially increase the understanding and communication of BRCA mutation status within families.
What evidence suggests that this trial's interventions could be effective for encouraging family testing for BRCA gene mutations?
Research shows that videos can help people discuss BRCA gene mutations with their families. Since BRCA mutations can increase the risk of certain cancers, family members should consider testing. In this trial, participants in one arm will receive a 2-minute infographic video via text message to share with family. Studies have found that videos simplify complex information, making it easier to understand and share. This might encourage more people to get tested, which is crucial for managing cancer risk. Although researchers are still exploring the use of videos in this context, they have succeeded in other health education areas, making them a promising tool here.12567
Who Is on the Research Team?
Leigha Senter, LGC
Principal Investigator
Ohio State University Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for individuals who have tested positive for BRCA1 or BRCA2 gene mutations. It's designed to see if they can encourage their family members to get tested too, using a video-based intervention sent via text.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either a video-based message via text or a family letter via mail to encourage information sharing about BRCA gene mutations
Follow-up
Participants are monitored for the impact of the intervention on information sharing and family dynamics
What Are the Treatments Tested in This Trial?
Interventions
- Video-Based Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor